ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...
Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...
The eye does not have a way to remove floaters, so you will have them as long as you live unless you do something about it.
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...
“Floaters” are bits of cellular debris in the vitreous humour, which is the gel-filled space in between the lens and the ...
I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small and have not significantly affected my vision. However, ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...
For people with both moderate-to-severe sleep apnea and obesity, the FDA-approved prescription medication Zepbound (tirzepatide) may help reduce body weight and, in turn, improve breathing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results